CNNWire The US Food and Drug Administration said Monday it had issued an emergency use authorization for Eli Lilly and Co's monoclonal antibody therapy to treat mild to moderate coronavirus infections in adults and children. The single antibody treatment, called bamlanivimab, must be infused in a hospital or other health care setting. It is the […]
